KLRA KLRA
Company Profile ↓Company Overview
KLRA (KLRA) is a publicly traded company listed on with a market capitalization of $2.14B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 41.8%, reflecting efficient use of shareholder capital.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -30.12% |
| 6 Months: | - |
| 3 Months: | -25.10% |
| 1 Month: | -18.30% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)45.53 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 41.8%.
CONS
- Trading 30.1% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 20.46M | 84.66M |
| Operating Income | -20.46M | -84.66M |
| EBITDA | -20.39M | -84.56M |
| Interest Expense | - | - |
| Pretax Income | -17.98M | -78.86M |
| Tax Provision | - | - |
| Net Income | -17.98M | -78.86M |
| Diluted EPS | -0.15 | -0.67 |
| R&D Expense | 10.13M | 70.87M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2025 |
|---|---|
| Revenue | 0 |
| Cost of Revenue | - |
| Gross Profit | - |
| Operating Expenses | 158.34M |
| Operating Income | -158.34M |
| EBITDA | -158.03M |
| Interest Expense | - |
| Pretax Income | -148.96M |
| Tax Provision | - |
| Net Income | -148.96M |
| Diluted EPS | -1.26 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 178.44M | 692.29M |
| Current Assets | 177.61M | 557.54M |
| Cash & Equivalents | 175.18M | 160.27M |
| Inventory | - | - |
| Receivables | 0 | 2.73M |
| Total Liabilities | 397.22M | 1.05B |
| Current Liabilities | 6.91M | 46.41M |
| Long Term Debt | - | - |
| Total Debt | 509.00K | 10.75M |
| Total Equity | -218.77M | -356.46M |
| Shares Outstanding | 117.95M | 117.95M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2025 |
|---|---|
| Operating Cash Flow | -120.21M |
| Investing Cash Flow | -492.60M |
| Financing Cash Flow | 598.66M |
| Capital Expenditure | -2.09M |
| Free Cash Flow | -122.30M |
| Net Change in Cash | -14.15M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2025 |
|---|---|
| Gross Margin % | - |
| Operating Margin % | - |
| Net Margin % | - |
| ROE % | 41.8% |
| ROCE % | -24.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for KLRA
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE1pR08xOW1ZYVJwSEktQTZQRTkwMmJaS2Zqc3pMOWs1dFNOZG5KZUxwd3pQcmxycmtvSEZmSm5rNzZVWjlxd3E4UVVnT1hQX1Br?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Kailera Therapeutics (KLRA) Stock Looks Overvalued Despite Its 20% Slump - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQTkxKNGRzNXI2OGlfZVpKYUx6dlBDNXJWTjZuMlQ3RmFCZFlLZk9oc2dZSnNIZzNtR0FKWElTdDZVTTAtdC00aUpjVXRZN09fQnRTd0ZvY2l3ekVtUnlFT3doZUJpdUtRMXJ2eS1GcTlPWGVLejUtYVNRVk9OU05PdkVLZVlyb2lhXy00R2…
Top Kailera Therapeutics (KLRA) Competitors 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQaGFVU2FGcG0wTDhueG5uZUMwZjl5ZFJBSlp6UlRNS2JYSzlsblRqQW1rR2J0b2dkWTlVTWdlNDNRWUMzb003Ml92dFZ3NFI1R1dyN2RXRnF1TlNSV1lfTEFTLTcybTYteFhBanRIcm5iaF9qSGJSWDFuOTJBYzk4NA?oc=5" target="_…
Kailera Therapeutics, Inc. Revenue Breakdown – NASDAQ:KLRA - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBMWFJFUko1Q3c0TEswQUlCRVpJd2xESzgxZTE0VHBCT0ZNak5aQ1JUQmFiTEYwWWZHU0tuMFRjaW1SaEt1UmF5MWZyU3haek9YRDJORXBGcy1iYnpob2lnNXppdUw2RnVtZE1PMjA0MGRZcWF3aDlF?oc=5" target="_blank">Kailera…
Kailera Therapeutics, Inc (KLRA) Stock Price Today: $16.94 - Gotrade
<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFA3clBiMkowYVhpY3ZlWVJvNlR2MmsyZVNMVzBud1pmMFhxZUZYempEZFZsSDBaVnBJbXA2QWlXUVFRdFltYU55UldsMUdTSnRfOW1TQkVMSQ?oc=5" target="_blank">Kailera Therapeutics, Inc (KLRA) Stock Price Toda…
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxQT0ZDcGlZZXNBQ19CMXVSdmF0cU01Sl9tdDJFc3F0a1c0U3diTzNNNkRIRjF2T1VKV21OeUxUck1zNG1YVEloR1N6Ry16M3p0eDc2M1RhZW9RUWFQYS1Lc1VCbWpOaF9EWUMxbm81NGxBYWxmNHNranByblF2MVg0ZERFRmVTbXB6WFNGa3…
KLRA — Frequently Asked Questions
What is the current share price of KLRA?
As of 2026-08-05 17:25 PDT, KLRA trades at $18.17 on NASDAQ/NYSE. Its 52-week range is $16.74 to $26.00.
What is the market capitalisation of KLRA?
KLRA has a market capitalisation of $2.14B on NASDAQ/NYSE.
What is the P/E ratio of KLRA?
KLRA trades at a trailing price-to-earnings (P/E) ratio of -14.39. Its price-to-book (P/B) ratio is -6.01.
What is the return on equity (ROE) of KLRA?
KLRA has a return on equity (ROE) of 41.79%. Its return on capital employed (ROCE) is -24.52%.
Is KLRA a good stock to buy?
This page provides a data-driven analysis of KLRA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.